BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 6,628 shares, a decrease of 39.1% from the August 31st total of 10,889 shares. Approximately 0.5% of the shares of the company are sold short. Based on an average daily volume of 12,544 shares, the short-interest ratio is presently 0.5 days.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, BIO-key International currently has an average rating of “Reduce”.
View Our Latest Stock Analysis on BIO-key International
BIO-key International Stock Down 18.2%
BIO-key International (NASDAQ:BKYI – Get Free Report) last released its earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.26. The company had revenue of $1.92 million for the quarter, compared to analysts’ expectations of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. Analysts expect that BIO-key International will post -1.62 EPS for the current year.
About BIO-key International
BIO-key International, Inc develops biometric identity and access management solutions designed to help organizations secure applications, devices and networks. Its offerings use fingerprint authentication and other authentication methods to provide alternatives or supplements to passwords, supporting secure access for employees, students, customers and other users.
The company’s products include biometric readers and related software, as well as its PortalGuard identity and access management platform.
See Also
- Five stocks we like better than BIO-key International
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
